Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
Read minutes of an important meeting held on 25 Nov 2013, in which Drugs Technical Advisory Board (DTAB) recommended a phase-out and ban of the use of plastic / PET containers in liquid oral formulations for primary packaging of paediatric formulations as well as formulations meant for geriatrics, women in …
Cadila Pharmaceuticals, on Thursday, launched a new lung cancer drug, Mycidac-C. The drug is priced at Rs.40,000 for a 10-course injection, much cheaper than the drugs manufactured and sold in the market by multinational companies at present. The drug, which will be available in the market in India early next …
The National Green Tribunal, Southern Bench on Monday ordered notice to Andhra Pradesh Government on a plea to restrain bulk drug manufacturing industries from causing pollution to Nakka Vagu river in Medak district. After admitting applications filed by Citizens Forum for Better Patancheru constituency, the Bench, comprising its judicial member …
The Supreme Court on Monday issued notice to PATH, an international NGO working in the health sector, on a PIL alleging that it indulged in unethical conduct of clinical trials in collaboration with ICMR in 2009-10 in Andhra Pradesh and Gujarat. A bench of Chief Justice P Sathasivam and justice …
Initiates petition in change.org asking SC to allow review and approval process to resume People for the Advancement of Clinical Research, (PACR) India, a group that claims to comprise ordinary healthy citizens, patients, government officials, health enterprise professionals, educators and patient advocacy groups have initiated a petition in the popular …
The bench tagged the case with other petitions on clinical trials being heard by a different bench The Supreme Court today issued notice to PATH, an international NGO working in the health sector, on a PIL alleging that it indulged in unethical conduct of clinical trials in collaboration with ICMR …
Goa State Pollution Control Board (GSPCB) has issued showcause notice to Sandu pharmaceuticals limited, as to why its unit at Pilerne industrial estate should not be directed to suspend or close its operation for operating in a manner that is causing water pollution in the vicinity. The showcause was issued …
An official at PCB confirmed development saying they had issued closure orders on Wednesday against Unit 5 of Mylan The Andhra Pradesh Pollution Control Board (APPCB) has issued a closure order against one of the manufacturing units owned by US generics drug maker Mylan Inc for violating effluent treatment norms. …
Clinical trials in the country must be to help the people and must not be allowed for the benefit of multinational companies, the Supreme Court said on Monday, while holding that the norms formulated by the Centre are “deficient” in protecting the people’s rights. While allowing trials for five entities, …
Judgement of the Delhi High Court in the matter of Bristol Myers Squibb Company & Others Vs. V.C. Bhutada & Others dated 11/10/2013 regarding infringement of Indian patent No. 203937 and damages, rendition of accounts and delivery up. Original Source: http://lobis.nic.in/dhc/SMD/judgement/11-10-2013/SMD11102013IA104032013.pdf
A vaccine against malaria could be introduced in the world’s worst-hit countries in 2015, after the latest trial of a treatment produced by Britain’s biggest drug company reduced the number of cases of the disease experienced by babies. The results of trials published on Tuesday in Durban, South Africa, showed …
India will soon be better armed to combat Japanese encephalitis (JE), a viral disease that affects the brain. Union health minister Ghulam Nabi Azad will launch the first ever indigenous JE vaccine on Friday. Produced under PPP by Bharat Biotech with Pune’s National Institute of Virology (NIV), the vaccine is …
The Supreme Court on Thursday said it will ‘test’ the new National Pharmaceutical Pricing Policy-2012 for fixing prices of essential medicines in the country and also the Drugs (Prices Control) Order, 2013 (DPCO 2013), notified by the government in May. Observing that the Centre is being guided by market-driven forces, …
Expressing concern over risks involved in clinical trials, the state government has advocated for a warning system to patients, who will be subject of the trials, that should be put in place apart from merely signing on documents. The state government has also suggested that there should be an online …
The Maharashtra Pollution Control Board (MPCB) has recently issued notices to as many as three companies in the city and ordered a major pharmaceutical company to shut down for flouting pollution control norms. Besides, the MPCB has also issued notices to 84 companies asking them to upgrade their technology so …
The Centre on Monday sought two weeks to apprise the Supreme Court on the safety mechanism put in place before commencement of the clinical trials with regard to new drugs/chemical entities. Besides, the apex court also asked the ministry of health and family welfare to place before it the existing …
The Centre also assured the apex court that it will not allow clinical trials for 162 drugs permitted by it earlier No clinical trials should be allowed for new drugs till a mechanism is put in place to monitor them and to protect the lives of people on which drugs …
The Rajasthan Government has argued for greater involvement of State Governments in the drug trial process along with online monitoring of trial subjects and provision of immediate medical care in cases of Serious Adverse Events (SAEs). The State made these and other recommendations during a meeting of Chief Secretaries/Health Secretaries …
Umbrella body mooted to oversee accreditation of institutions and for setting up ethics committees An official expert committee has recommended major changes in the guidelines for approval of new drugs, clinical trials and banning of medicines. It suggested setting up of a council to oversee the accreditation of institutions, clinical …
After the government failed to include the traditional stream of medicines in the Drugs and Cosmetics (amendment) Bill, 2013, it is now mulling a separate legislation to regulate systems such as ayurveda and homeopathy. According to official sources, the department of AYUSH, which administers development of ayurveda, yoga & naturopathy, …
